AAAAAA
Results:
1-13
|
Results: 13
Authors:
van der Bom, JG
Bots, ML
Haverkate, F
Meijer, F
Hofman, A
Kluft, C
Grobbee, DE
Citation: Jg. Van Der Bom et al., Activation products of the haemostatic system in coronary, cerebrovascularand peripheral arterial disease, THROMB HAEM, 85(2), 2001, pp. 234-239
Authors:
Haverkate, F
Citation: F. Haverkate, C-Reactive protein as cardiovascular risk factor - A discovery by ECAT, CLIN CH L M, 38(10), 2000, pp. 1055-1055
Authors:
Marchi, R
Lundberg, U
Grimbergen, J
Koopman, J
Torres, A
de Bosch, NB
Haverkate, F
Pinango, CLA
Citation: R. Marchi et al., Fibrinogen Caracas V, an abnormal fibrinogen with an A alpha 532 Ser -> Cys substitution associated with thrombosis, THROMB HAEM, 84(2), 2000, pp. 263-270
Authors:
de Maat, MPM
Meijer, P
Nieuwenhuizen, W
Haverkate, F
Kluft, C
Citation: Mpm. De Maat et al., Performance of semiquantitative and quantitative D-dimer assays in the ECAT External Quality Assessment Program, SEM THROMB, 26(6), 2000, pp. 625-630
Authors:
de Maat, MPM
Ossewaarde, JM
Verheggen, PWHM
Kluft, C
Cats, VM
Haverkate, F
Citation: Mpm. De Maat et al., Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris, ATHEROSCLER, 153(2), 2000, pp. 499-504
Authors:
Lowe, GDO
Haverkate, F
Thompson, SG
Turner, RM
Bertina, RM
Turpie, AGG
Mannucci, PM
Citation: Gdo. Lowe et al., Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT study, THROMB HAEM, 81(6), 1999, pp. 879-886
Authors:
van der Bom, JG
Bots, ML
Haverkate, F
Meyer, P
Hofman, A
Grobbee, DE
Kluft, C
Citation: Jg. Van Der Bom et al., Fibrinolytic activity in peripheral atherosclerosis in the elderly, THROMB HAEM, 81(2), 1999, pp. 275-280
Authors:
Verheggen, PWHM
de Maat, MPM
Cats, VM
Haverkate, F
Zwinderman, AH
Kluft, C
Bruschke, AVG
Citation: Pwhm. Verheggen et al., Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function, EUR HEART J, 20(8), 1999, pp. 567-574
Authors:
Braat, EAM
Levi, M
Bos, R
Haverkate, F
Lassen, MR
de Maat, MPM
Rijken, DC
Citation: Eam. Braat et al., Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects, J LA CL MED, 134(2), 1999, pp. 161-167
Authors:
de Maat, MPM
Haverkate, F
Kluft, C
Citation: Mpm. De Maat et al., C-reactive protein: a cardiovascular risk factor - Report on the CRP hot-topic workshop October 1, 1997, FIBRINOL PR, 12(6), 1998, pp. 323-327
Authors:
Bots, ML
van Kooten, F
Breteler, MMB
Slagboom, PE
Hofman, A
Haverkate, F
Meijer, P
Koudstaal, PJ
Grobbee, DE
Kluft, C
Citation: Ml. Bots et al., Response to activated protein c in subjects with and without dementia - The Dutch vascular factors in dementia study, HAEMOSTASIS, 28(3-4), 1998, pp. 209-215
Authors:
Bots, ML
Breteler, MMB
van Kooten, F
Haverkate, F
Meijer, P
Koudstaal, PJ
Grobbee, DE
Kluft, C
Citation: Ml. Bots et al., Coagulation and fibrinolysis markers and risk of dementia - The Dutch vascular factors in dementia study, HAEMOSTASIS, 28(3-4), 1998, pp. 216-222
Authors:
Lowe, GDO
Haverkate, F
Citation: Gdo. Lowe et F. Haverkate, Specificity of haemostasis abnormalities for vascular phenotypes, HAEMOSTASIS, 28(3-4), 1998, pp. 223-227
Risultati:
1-13
|